FDA NDC Directory · JSON-LD · Markdown

Tigecycline

NDC 0781-3481 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA091620
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS PARENTERAL
Active ingredientsTIGECYCLINE (50 mg/10mL)
Marketing started20171130
Package count1

External sources

Source: openFDA. Public-domain (CC0).